4162 On Other Exchanges
Symbol
Exchange
4162 is not on other exchanges.

pharmaengine inc (4162) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMAENGINE INC (4162)
\

Related News

No related news articles were found.

pharmaengine inc (4162) Related Businessweek News

No Related Businessweek News Found

pharmaengine inc (4162) Details

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs to treat cancer and Asian prevalent diseases in Taiwan. It is developing ONIVYDE, a liposome encapsulation of irinotecan for target indications, including pancreatic, gastric, colorectal, breast, and brain cancers, as well as Ewing’s sarcoma; PEP503, a nanoparticle formulation of hafnium oxide for indications comprising head and neck, liver, rectal, and prostate cancers, as well as soft tissue sarcoma; and PEP06 for solid tumors. The company has collaborations with Merrimack Pharmaceuticals, Inc.; Nanobiotix S.A.; and Guangzhou BeBetter Medicine Technology Co., Ltd. PharmaEngine, Inc. was founded in 2003 and is based in Taipei, Taiwan.

Founded in 2003

pharmaengine inc (4162) Top Compensated Officers

Founder, Chief Executive Officer, President &...
Total Annual Compensation: 18.6M
Vice President of Finance & Administration
Total Annual Compensation: 3.3M
Vice President of Clinical & Regulatory Affai...
Total Annual Compensation: 3.9M
Compensation as of Fiscal Year 2016.
pharmaengine inc
PharmaEngine, Inc. - Special Call

PharmaEngine, Inc. - Special Call

PharmaEngine, Inc. Presents at China Healthcare Investment Conference, Mar-28-2018 11:20 AM

PharmaEngine, Inc. Presents at China Healthcare Investment Conference, Mar-28-2018 11:20 AM. Venue: Ritz-Carlton Shanghai Pudong Hotel, Shanghai, China. Speakers: Grace Yeh, CEO.

PharmaEngine, Inc. Presents at Taiwan Corporate Day 2017 - Hong Kong, Oct-18-2017

PharmaEngine, Inc. Presents at Taiwan Corporate Day 2017 - Hong Kong, Oct-18-2017 . Venue: Hong Kong, Hong Kong.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4162 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4162.
View Industry Companies
 

Industry Analysis

4162

Industry Average

Valuation 4162 Industry Range
Price/Earnings 54.1x
Price/Sales 24.5x
Price/Book 5.3x
Price/Cash Flow 53.9x
TEV/Sales 20.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PHARMAENGINE INC, please visit www.pharmaengine.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.